RAPID AND SIMPLE METHOD FOR MEASURING BIOGENIC AMINES AND METABOLITES IN BRAIN HOMOGENATES BY HPLC-ELECTROCHEMICAL DETECTIONZACZEK R; COYLE JT.1982; J. NEURAL TRANSM.; ISSN 0300-9564; AUT; DA. 1982; VOL. 53; NO 1; PP. 1-5; BIBL. 8 REF.Article

EXCITATORY AMINO ACID ANALOGUES: NEUROTOXICITY AND SEIZURESZACZEK R; COYLE JT.1982; NEUROPHARMACOLOGY; ISSN 0028-3908; GBR; DA. 1982; VOL. 21; NO 1; PP. 15-26; BIBL. 2 P.Article

KAINIC ACID STIMULATES EXCITATORY AMINO ACID NEUROTRANSMITTER RELEASE AT PRESYNAPTIC RECEPTORSFERKANY JW; ZACZEK R; COYLE JT et al.1982; NATURE (LOND.); ISSN 0028-0836; GBR; DA. 1982; VOL. 298; NO 5876; PP. 757-759; BIBL. 25 REF.Article

EVIDENCE FOR A HIPPOCAMPAL-SEPTAL GLUTAMATERGIC PATHWAY IN THE RATZACZEK R; HEDREEN JC; COYLE JT et al.1979; EXPER. NEUROL.; USA; DA. 1979; VOL. 65; NO 1; PP. 145-156; BIBL. 33 REF.Article

EFFECTS OF ANAESTHETICS AND ANTICONVULSANTS ON THE ACTION OF KAINIC ACID IN THE RAT HIPPOCAMPUSZACZEK R; NELSON MF; COYLE JT et al.1978; EUROP. J. PHARMACOL.; NLD; DA. 1978; VOL. 52; NO 3-4; PP. 323-327; BIBL. 9 REF.Article

KAINIC ACID NEUROTOXICITY AND SEIZURESZACZEK R; NELSON M; COYLE JT et al.1981; NEUROPHARMACOLOGY; ISSN 0028-3908; GBR; DA. 1981; VOL. 20; NO 2; PP. 183-189; BIBL. 28 REF.Article

MICROINJECTION OF KAINIC ACID INTO THE RAT HIPPOCAMPUSSCHWARCZ R; ZACZEK R; COYLE JT et al.1978; EUROP. J. PHARMACOL.; NLD; DA. 1978; VOL. 50; NO 3; PP. 209-220; BIBL. 1 P.Article

N-ACETYLASPARTYLGLUTAMATE: AN ENDOGENOUS PEPTIDE WITH HIGH AFFINITY FOR A BRAIN GLUTAMATE RECEPTORZACZEK R; KOLLER K; COTTER R et al.1983; PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. BIOLOGICAL SCIENCES; ISSN 0273-1134; USA; DA. 1983; VOL. 80; NO 4; PP. 1116-1119; BIBL. 25 REF.Article

Unique properties of norepinephrine release from terminals arising from the locus coeruleus : high potassium sensitivity and lack of linopirdine (DuP 996) enhancementZACZEK, R; TINKER, W. J; TAM, S. W et al.Neuroscience letters. 1993, Vol 155, Num 1, pp 107-111, issn 0304-3940Article

Glutamate-containing dipeptides enhance specific binding at glutamate receptors and inhibit specific binding at kainate receptors in rat brainFERKANY, J; ZACZEK, R; MARKL, A et al.Neuroscience letters. 1984, Vol 44, Num 3, pp 281-286, issn 0304-3940Article

A simple method for quantitative electroencephalographic assessment of drugs with convulsant and anticonvulsant propertiesZACZEK, R; MARKL, A; BALM, M et al.Journal of neuroscience methods. 1986, Vol 18, Num 4, pp 351-360, issn 0165-0270Article

Dopamine transporter : expression in Xenopus oocytesUHL, G. R; O'HARA, B; SHIMADA, S et al.Molecular brain research. 1991, Vol 9, Num 1-2, pp 23-29, issn 0169-328X, 7 p.Article

Methylphenidate and pemoline do not cause depletion of rat brain monoamine markers similar to that observed with methamphetamineZACZEK, R; BATTAGLIA, G; CONTRERA, J. F et al.Toxicology and applied pharmacology. 1989, Vol 100, Num 2, pp 227-233, issn 0041-008XArticle

Quisqualate-sensitive, chloride-dependent transport of glutamate into rat brain synaptosomesZACZEK, R; BALM, JM; ARLIS, S et al.Journal of neuroscience research. 1987, Vol 18, Num 3, pp 425-431, issn 0360-4012Article

Cerebrospinal fluid homovanillic acid and Parkinsonism in Huntington's diseaseKURLAN, R; GOLDBLATT, D; ZACZEK, R et al.Annals of neurology. 1988, Vol 24, Num 2, pp 282-284, issn 0364-5134Article

Comparison of the effects of repeated oral versus subcutaneous fenfluramine administration on rat brain monoamine neurons : pharmacokinetic and dose-response dataDE SOUZA, E. B; ZACZEK, R; CULP, S et al.Pharmacology, biochemistry and behavior. 1991, Vol 39, Num 4, pp 963-969, issn 0091-3057Article

Interactions of [³H]amphetamine with rat brain synaptosomes. I: Saturable sequestrationZACZEK, R; CULP, S; GOLDBERG, H et al.The Journal of pharmacology and experimental therapeutics. 1991, Vol 257, Num 2, pp 820-829, issn 0022-3565, 10 p.Article

A simulation of T-wave alternans vectocardiographic representation performed by changing the ventricular heart cells action potential durationJANUSEK, D; KANIA, M; ZACZEK, R et al.Computer methods and programs in biomedicine (Print). 2014, Vol 114, Num 1, pp 102-108, issn 0169-2607, 7 p.Article

Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complexGRIGORIADIS, D. E; ZACZEK, R; PEARSALL, D. M et al.Endocrinology (Philadelphia). 1989, Vol 125, Num 6, pp 3068-3077, issn 0013-7227Article

Effects of linopirdine, HP 749, and glycyl-prolyl-glutamate on transmitter release and uptakeZACZEK, R; TINKER, W. J; LOGUE, A. R et al.Drug development research. 1993, Vol 29, Num 3, pp 203-208, issn 0272-4391Article

N-acetylaspartylglutamate: possible role as the neurotransmitter of the lateral olfactory tractFRENCH-MULLEN, J. M. H; KOLLER, K; ZACZEK, R et al.Proceedings of the National Academy of Sciences of the United States of America. 1985, Vol 82, Num 11, pp 3897-3900, issn 0027-8424Article

Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonistsBECK, J. P; ARVANITIS, A. G; CURRY, M. A et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 7, pp 967-972, issn 0960-894XArticle

4-(1,3-dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)-pyrazolo[1,5 -a]-1,3,5-triazine : A potent, orally bioavailable CRF₁ receptor antagonistLIQI HE; GILLIGAN, P. J; TRAINOR, G et al.Journal of medicinal chemistry (Print). 2000, Vol 43, Num 3, pp 449-456, issn 0022-2623Article

Role for brain corticotropin-releasing factor in the wreight-reducing effects of chronic flenfluramine treatment in ratsAPPEL, N. M; OWENS, M. J; CULP, S et al.Endocrinology (Philadelphia). 1991, Vol 128, Num 6, pp 3237-3246, issn 0013-7227, 10 p.Article

Cerebrospinal fluid correlates of depression in Huntington's diseaseKURLAN, R; CAINE, E; RUBIN, A et al.Archives of neurology (Chicago). 1988, Vol 45, Num 8, pp 881-883, issn 0003-9942Article